Cargando…

Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease

BACKGROUND: Vascular risk factors such as atherosclerosis, diabetes, and elevated homocysteine levels are strongly correlated with onset of Alzheimer's disease (AD). Emerging evidence indicates that blood coagulation protein thrombin is associated with vascular and non-vascular risk factors of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bihaqi, Syed Waseem, Rao, Haripriya Vittal, Sen, Abhik, Grammas, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616330/ https://www.ncbi.nlm.nih.gov/pubmed/36324711 http://dx.doi.org/10.1016/j.cccb.2021.100014

Ejemplares similares

High Glucose and Hypoxia-Mediated Damage to Human Brain Microvessel Endothelial Cells Induces an Altered, Pro-Inflammatory Phenotype in BV-2 Microglia In Vitro
por: Iannucci, Jaclyn, et al.
Publicado: (2020)

Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model
por: Iannucci, Jaclyn, et al.
Publicado: (2020)

Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia
por: Tripathy, Debjani, et al.
Publicado: (2013)

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
por: Grossmann, Klaus
Publicado: (2021)

Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer’s Disease
por: Iannucci, Jaclyn, et al.
Publicado: (2020)

Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro
por: Iannucci, Jaclyn, et al.
Publicado: (2021)

Dabigatran Monitoring Was Influenced by Thrombin Time Reagent With Different Thrombin Concentrations
por: Xu, Xiaoping, et al.
Publicado: (2019)

Thrombin, a Key Driver of Pathological Inflammation in the Brain
por: Iannucci, Jaclyn, et al.
Publicado: (2023)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
Publicado: (2010)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency
por: Gribkova, Irina V., et al.
Publicado: (2016)

Developmental lead exposure and lifespan alterations in epigenetic regulators and their correspondence to biomarkers of Alzheimer's disease
por: Eid, Aseel, et al.
Publicado: (2016)

Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts
por: Altieri, Paola, et al.
Publicado: (2018)

Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway
por: Ewees, Mohamed Gamal El-Din, et al.
Publicado: (2021)

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
por: Grammas, Paula
Publicado: (2011)

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation
por: Jaffer, Iqbal H, et al.
Publicado: (2015)

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
por: Liu, Zhiyan, et al.
Publicado: (2022)

Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease
por: Zolezzi, Juan M., et al.
Publicado: (2017)

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
por: Sobue, Akira, et al.
Publicado: (2023)

Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
por: Mirdamadi, Ahmad
Publicado: (2013)

In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats
por: Bihaqi, Syed Waseem, et al.
Publicado: (2011)

Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain
por: Bihaqi, Syed Waseem, et al.
Publicado: (2012)

Neuroinflammation, AD, and Dementia
por: Reale, Marcella, et al.
Publicado: (2010)

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016)

Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity
por: Dólleman, Sophie C., et al.
Publicado: (2022)

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
por: Richards, Guy A., et al.
Publicado: (2018)

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
por: Dahl, Ola E
Publicado: (2012)

Dabigatran antagonizes growth, cell‐cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines
por: Vianello, Fabrizio, et al.
Publicado: (2016)

Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
por: Artang, Ramin, et al.
Publicado: (2017)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)
por: Zhao, Y, et al.
Publicado: (2015)

Sex Differences in Metabolic Indices and Chronic Neuroinflammation in Response to Prolonged High-Fat Diet in ApoE4 Knock-In Mice
por: Mattar, Jennifer M., et al.
Publicado: (2022)

The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Relevance of Neuroinflammation and Encephalitis in Autism
por: Kern, Janet K., et al.
Publicado: (2016)

Neuroinflammation in Alzheimer’s disease
por: Zhang, Fengjin, et al.
Publicado: (2015)

Neuroinflammation in Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE(−/−)–LDLR(−/−) Double-Knockout Mice
por: Sanda, Tomohide, et al.
Publicado: (2020)

Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys
por: Wong, Pancras C., et al.
Publicado: (2021)

The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_99loudevsvsa8g6b5t8u14u5go